Related Experiment Video
Updated: Jul 19, 2026

Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Artificial carriers: a strategy for constructing antigenic/immunogenic conjugates
Maria Sakarellos-Daitsiotis1, Dimitrios Krikorian, Eugenia Panou-Pomonis
1Department of Chemistry, Section of Organic Chemistry and Biochemistry, University of Ioannina, 45110 Ioannina, Greece. msakarel@cc.uoi.gr
Researchers are developing artificial carriers to create potent vaccines and diagnostic tools. A novel helicoid-type Sequential Oligopeptide Carrier (SOCn) shows promise for improved antigen and immunogen generation.
Area of Science:
- Biotechnology
- Immunology
- Vaccine Development
Background:
- Artificial carriers are crucial for designing effective vaccines and diagnostic tools by presenting multiple epitopes.
- Current efforts focus on creating reliable and versatile antigenic substrates for various biochemical applications.
Purpose of the Study:
- To review different types of artificial carriers used in vaccine and immunoassay development.
- To highlight the construction and application of a novel helicoid-type Sequential Oligopeptide Carrier (SOCn).
Main Methods:
- Review of existing artificial carrier types including dendrimers, multimeric cores, and folding templates.
- Detailed examination of the structure and function of the Sequential Oligopeptide Carrier (SOCn).
Main Results:
- Artificial carriers enable the development of sensitive immunoassays and specific antibodies for vaccine candidates.
- The SOCn carrier facilitates favorable peptide arrangement, preserving active conformation for potent antigen and immunogen generation.
Conclusions:
- Artificial carriers, particularly the SOCn, offer a versatile platform for constructing advanced immunogens and antigenic substrates.
- The rational design of these carriers is key to enhancing vaccine efficacy and immunoassay performance.
More Related Videos
10:16Fabrication of Anisotropic Polymeric Artificial Antigen Presenting Cells for CD8+ T Cell Activation
Published on: October 12, 2018
10:35Chemical Conjugation of a Purified DEC-205-Directed Antibody with Full-Length Protein for Targeting Mouse Dendritic Cells In Vitro and In Vivo
Published on: February 5, 2021
Related Concept Videos
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Vaccinations
Vaccine Production